| Dr Alan Howard Shein, MD | |
|
444 N Main St, 6th Floor, Akron, OH 44310-3110 | |
| (330) 379-8190 | |
| (330) 379-8191 |
| Full Name | Dr Alan Howard Shein |
|---|---|
| Gender | Male |
| Speciality | Addiction Medicine |
| Experience | 41 Years |
| Location | 444 N Main St, Akron, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437126653 | NPI | - | NPPES |
| 0123404 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084A0401X | Psychiatry & Neurology - Addiction Medicine | 35061631 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Summa Health System | Akron, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Summa Physicians Inc | 2961303532 | 640 |
News Archive
immatics biotechnologies GmbH, a biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, announced today that it has raised EUR53.8million in a Series C financing round. The new funds will allow the Company to finance the ongoing development of immatics' existing pipeline of advanced therapeutic cancer vaccine candidates.
Patients with renal cell carcinoma tumours larger than 4 cm benefit from undergoing elective partial nephrectomy rather than radical nephrectomy surgery, a study has found.
Two previously unrecognized genetic markers may predict whether breast cancer patients would benefit from chemotherapy followed by tamoxifen, according to preclinical research from Roswell Park Cancer Institute, in collaboration with the cooperative research group SWOG and St. Jude Children's Research Hospital. The results of this research will be presented at the American Association for Cancer Research Annual Meeting 2016, to be held April 16-20 in New Orleans.
Patients undergoing treatment for melanoma that has spread to the liver may respond well to chemotherapy delivered directly into the liver's blood vessels, according to a study sponsored by the National Cancer Institute and Delcath Systems Inc., and led by James F. Pingpank, M.D., associate professor of surgery, University of Pittsburgh School of Medicine, and surgical oncologist with UPMC Cancer Centers. The results will be disclosed in an oral presentation on June 5 in Chicago at the 46th annual meeting of the American Society of Clinical Oncology (ASCO).
A study based on a contemporary registry of patients with myocardial infarction (heart attack) indicates that even though hospitals that perform a higher number of angioplasties are more likely to follow evidence-based guidelines and have shorter times to the angioplasty procedure, there appears to be no significant difference in outcomes such as length of hospital stay or risk of death, according to a study in the November 25 issue of JAMA.
› Verified 4 days ago
| Entity Name | Summa Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235167719 PECOS PAC ID: 2961303532 Enrollment ID: O20040116000295 |
News Archive
immatics biotechnologies GmbH, a biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, announced today that it has raised EUR53.8million in a Series C financing round. The new funds will allow the Company to finance the ongoing development of immatics' existing pipeline of advanced therapeutic cancer vaccine candidates.
Patients with renal cell carcinoma tumours larger than 4 cm benefit from undergoing elective partial nephrectomy rather than radical nephrectomy surgery, a study has found.
Two previously unrecognized genetic markers may predict whether breast cancer patients would benefit from chemotherapy followed by tamoxifen, according to preclinical research from Roswell Park Cancer Institute, in collaboration with the cooperative research group SWOG and St. Jude Children's Research Hospital. The results of this research will be presented at the American Association for Cancer Research Annual Meeting 2016, to be held April 16-20 in New Orleans.
Patients undergoing treatment for melanoma that has spread to the liver may respond well to chemotherapy delivered directly into the liver's blood vessels, according to a study sponsored by the National Cancer Institute and Delcath Systems Inc., and led by James F. Pingpank, M.D., associate professor of surgery, University of Pittsburgh School of Medicine, and surgical oncologist with UPMC Cancer Centers. The results will be disclosed in an oral presentation on June 5 in Chicago at the 46th annual meeting of the American Society of Clinical Oncology (ASCO).
A study based on a contemporary registry of patients with myocardial infarction (heart attack) indicates that even though hospitals that perform a higher number of angioplasties are more likely to follow evidence-based guidelines and have shorter times to the angioplasty procedure, there appears to be no significant difference in outcomes such as length of hospital stay or risk of death, according to a study in the November 25 issue of JAMA.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alan Howard Shein, MD 444 N Main St, 6th Floor, Akron, OH 44310-3110 Ph: (330) 379-8190 | Dr Alan Howard Shein, MD 444 N Main St, 6th Floor, Akron, OH 44310-3110 Ph: (330) 379-8190 |
News Archive
immatics biotechnologies GmbH, a biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, announced today that it has raised EUR53.8million in a Series C financing round. The new funds will allow the Company to finance the ongoing development of immatics' existing pipeline of advanced therapeutic cancer vaccine candidates.
Patients with renal cell carcinoma tumours larger than 4 cm benefit from undergoing elective partial nephrectomy rather than radical nephrectomy surgery, a study has found.
Two previously unrecognized genetic markers may predict whether breast cancer patients would benefit from chemotherapy followed by tamoxifen, according to preclinical research from Roswell Park Cancer Institute, in collaboration with the cooperative research group SWOG and St. Jude Children's Research Hospital. The results of this research will be presented at the American Association for Cancer Research Annual Meeting 2016, to be held April 16-20 in New Orleans.
Patients undergoing treatment for melanoma that has spread to the liver may respond well to chemotherapy delivered directly into the liver's blood vessels, according to a study sponsored by the National Cancer Institute and Delcath Systems Inc., and led by James F. Pingpank, M.D., associate professor of surgery, University of Pittsburgh School of Medicine, and surgical oncologist with UPMC Cancer Centers. The results will be disclosed in an oral presentation on June 5 in Chicago at the 46th annual meeting of the American Society of Clinical Oncology (ASCO).
A study based on a contemporary registry of patients with myocardial infarction (heart attack) indicates that even though hospitals that perform a higher number of angioplasties are more likely to follow evidence-based guidelines and have shorter times to the angioplasty procedure, there appears to be no significant difference in outcomes such as length of hospital stay or risk of death, according to a study in the November 25 issue of JAMA.
› Verified 4 days ago
Margaret C Mcbride, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-8050 Fax: 330-543-8054 | |
Dr. Marnie Alexandra Mcgrath, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 444 N Main St, #400, Akron, OH 44310 Phone: 330-344-6440 | |
Thiruvengadam Kulasekaran, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 300 Locust St, Suite 150, Akron, OH 44302 Phone: 330-253-2113 Fax: 330-253-2362 | |
Ann Christina Ciancone, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 4125 Medina Rd, Akron, OH 44333 Phone: 330-665-8168 Fax: 330-665-8087 | |
Sumru Bilge-johnson, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 215 W Bowery St, Akron, OH 44308 Phone: 330-543-4382 Fax: 330-543-3856 | |
Dr. Christopher Michael Durner, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 444 N Main St, Akron, OH 44310 Phone: 330-379-5235 Fax: 330-379-9226 | |
Dr. Eileen M Schwartz, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 150 Cross Street, Akron, OH 44311 Phone: 330-253-9388 Fax: 330-376-6726 |